The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 16, 2024
Filed:
Apr. 05, 2019
Applicant:
Calasia Pharmaceuticals, Inc., San Diego, CA (US);
Inventors:
Surya Kanta De, San Diego, CA (US);
Sridhar G. Prasad, San Diego, CA (US);
Marshall Clarke Peterman, Oceanside, CA (US);
Bernard Collins, Cardiff, CA (US);
Assignee:
CALASIA PHARMACEUTICALS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/6615 (2006.01); A61K 31/12 (2006.01); A61P 27/10 (2006.01); A61P 25/16 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/6615 (2013.01); A61K 31/12 (2013.01); A61P 25/16 (2018.01); A61P 27/10 (2018.01); A61P 43/00 (2018.01);
Abstract
Methods of treating presbyopia or cataract in a subject in need thereof are provided. The methods require administering to the subject an effective amount of a composition comprising a compound that inhibits the formation of high molecular weight aggregates of human α-A-crystallin. Compositions containing certain compounds are believed to be also effective in the treatment of transthyretin (TTR)-associated amyloidosis and Parkinson's disease.